A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2011
10/20/2011	US20110256214 Single-time vaccines
10/20/2011	US20110256213 Phospholipid micellar and liposomal compositions and uses thereof
10/20/2011	US20110256212 Use of 8-Quinolinol and its Analogs to Target Cancer Stem Cells
10/20/2011	US20110256211 Transdermal Delivery
10/20/2011	US20110256210 Transdermal Delivery
10/20/2011	US20110256209 Skin patch for improving menstrual
10/20/2011	US20110256207 Whole grain flour and products including same
10/20/2011	US20110256206 Implantable devices for treating hiv
10/20/2011	US20110256203 Porous ceramic scaffold having an organic/inorganic hybrid coating layer containing bioactive factor and method thereof
10/20/2011	US20110256202 Immunocompatible amniotic membrane products
10/20/2011	US20110256201 Hydrolyzed hydrogels
10/20/2011	US20110256199 Melt extrusion encapsulation of flavors and other encapsulates in a carrier containing spices and herbs
10/20/2011	US20110256193 Use Of Copolymers Based On Polyethers And Vinyl Monomers As Stabilizing Agents For Emulsions
10/20/2011	US20110256192 Photoprotective composition containing an unmodified gelling starch and polyamide particles
10/20/2011	US20110256190 Modified release compositions comprising tacrolimus
10/20/2011	US20110256189 Coating material for solid medicine and solid medicine formed with same
10/20/2011	US20110256188 Dry powder pharmaceutical composition for inhalation
10/20/2011	US20110256187 Biofilm-inhibitory coatings that release salicyclic acid by hydrolisis
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256185 Reinforced tissue shields
10/20/2011	US20110256184 Non-ordered Mesoporous Silica Structure for Biomolecule Loading and Release
10/20/2011	US20110256183 Hydrogels with network defects enhanced by nanoparticle incorporation
10/20/2011	US20110256182 Genes encoding major capsid protein l1 of human papilloma virus
10/20/2011	US20110256106 Methods and Compositions for Treating Intervertebral Disc Degeneration
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256072 Food and composition each comprising phosphorylated saccharide, polyphenol and fluoride
10/20/2011	US20110256071 Thiol-containing fragrance and flavor materials
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same
10/20/2011	US20110256069 Pharmaceutical Moire Pill
10/20/2011	US20110256066 Method for preparing engineered mg doped ferrite superparamagnetic nano particle exhibiting ac magnetic induction heating at high temperature and mg doped ferrite superparamagnetic nano particles engineered by the method
10/20/2011	US20110256059 Nanoparticulate systems prepared from anionic polymers
10/20/2011	US20110253633 Catanionic vesicles, process for preparing same and applications thereof
10/20/2011	US20110253140 Formulations containing large-size carrier particles for dry powder inhalation aerosols
10/20/2011	US20110253135 Metal coordination complexes of volatile drugs
10/20/2011	US20110253133 Methods and compositions for administration of oxybutynin
10/20/2011	DE102010015143A1 Stabile flüssige ölige gebrauchsfertige Formulierungen, Herstellung davon und Verwendung davon A stable liquid oily formulations ready, preparation thereof and use thereof
10/20/2011	CA2833090A1 Oral pharmaceutical dispersion compositions
10/20/2011	CA2802142A1 Ciprofloxacin dry syrup composition
10/20/2011	CA2799550A1 Stabilized statin formulations
10/20/2011	CA2796575A1 Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
10/20/2011	CA2796334A1 Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
10/20/2011	CA2796268A1 Methods for treatment of sleep-related breathing disorders
10/20/2011	CA2796197A1 Compositions comprising polyglutamic acid nanoparticles and polypeptides such as cd40 agonists
10/20/2011	CA2796168A1 Acetaminophen composition
10/20/2011	CA2796139A1 Low-dosed solid oral dosage forms for hrt
10/20/2011	CA2796021A1 Improvements relating to antiviral compositions
10/20/2011	CA2795908A1 Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same
10/20/2011	CA2795886A1 Methods and compositions for improving implant osseointegration
10/20/2011	CA2795801A1 Very low-dosed solid oral dosage forms for hrt
10/20/2011	CA2795723A1 Method and ophthalmic composition for treating retinal disease
10/20/2011	CA2791291A1 Easily appliable, storage stable, radiation-curable, pigmented, artificial nail gel coatings
10/20/2011	CA2769678A1 Extracts of poria cocos and phragmites kharka
10/19/2011	EP2377871A1 1-(2h)-isoquinolone derivative
10/19/2011	EP2377810A1 Regular hexahedral or octahedral ferrite nanoparticle, and method for producing same
10/19/2011	EP2377578A1 Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof
10/19/2011	EP2377577A1 A benzyl alcohol mixture for treating premature ejaculation
10/19/2011	EP2377574A2 Implant and applicator
10/19/2011	EP2377558A2 Composition for improving inflammatory disease using abh antigens
10/19/2011	EP2377557A2 Compositions comprising azelastine and methods of use thereof
10/19/2011	EP2377554A1 Concentrated protein lyophilates, methods and uses
10/19/2011	EP2377543A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally ocurring plant compounds, extracts and derivatives
10/19/2011	EP2377540A1 Transdermal patch containing 17-deacetyl norgestimate
10/19/2011	EP2377538A1 Aqueous oral preparation of stable amlodipine
10/19/2011	EP2377535A1 Method and composition for treating multiple sclerosis (variants)
10/19/2011	EP2377529A1 Use of racemates of pinocembrin in preparing medicaments for treating stroke
10/19/2011	EP2377526A1 Fast dissolving drug delivery systems
10/19/2011	EP2377525A1 Duloxetine enteric pellets
10/19/2011	EP2377524A1 Method of stabilizing reduced coenzyme Q10
10/19/2011	EP2377523A1 Forms of medicine with improved pharmokinetic characteristics
10/19/2011	EP2377522A1 Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
10/19/2011	EP2377521A1 Pharmaceutical formulations of telmisartan and diuretic combination
10/19/2011	EP2377520A1 Pharmaceutical compound of prasugrel
10/19/2011	EP2377519A2 Pharmaceutical Composition Comprising Octreotide Microparticles
10/19/2011	EP2377518A1 Stable aliskiren formulations
10/19/2011	EP2377517A2 Pharmaceutical composition containing an anionic drug, and a production method therefor
10/19/2011	EP2377516A1 Acetaminophen composition
10/19/2011	EP2377515A1 Patch preparation and production method thereof
10/19/2011	EP2377514A2 Liquid parenteral formulation comprising a tramadol material and paracetamol
10/19/2011	EP2377505A1 Method for producing liposomal drugs and a device for producing a liposome
10/19/2011	EP2377498A1 Pressure-sensitive adhesive tape package
10/19/2011	EP2377406A1 Apparatus for encapsulating materials
10/19/2011	EP2376196A1 Animal treatment formulation and methods of use
10/19/2011	EP2376129A1 Chlorhexidine acetate antiseptic cleaning agent
10/19/2011	EP2376115A1 Methods and systems for inducing immunologic tolerance to non-self antigens
10/19/2011	EP2376103A1 Cyclosporine compositions for enhancing nail growth
10/19/2011	EP2376096A2 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus
10/19/2011	EP2376086A1 Treatment of vaginal atrophy in women with cardiovascular pathology risk
10/19/2011	EP2376077A2 Composition and method for treatment of diabetes
10/19/2011	EP2376075A2 Nasal formulations of metoclopramide
10/19/2011	EP2376071A2 Method for preparing microspheres and microspheres produced thereby
10/19/2011	EP2376070A2 Octreotide depot formulation with constantly high exposure levels
10/19/2011	EP2376069A2 Microparticles comprising adipose stem cells
10/19/2011	EP2376068A2 Methods for enhancing the release and absorption of water insoluble active agents
10/19/2011	EP2376067A2 Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
10/19/2011	EP2376066A1 Low dose controlled release tablet
10/19/2011	EP2376065A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
10/19/2011	EP2376064A1 Porous structures with modified biodegradation kinetics
10/19/2011	EP2376063A1 Novel form of administering osteogenic protein complexes
10/19/2011	EP2376062A1 Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug
10/19/2011	EP2376061A1 Aqueous coacervate composition comprising poorly water-soluble biologically-active agents

1 ... 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 ... 2991